Reviewer	Representation	Employment	Consultant	Speakers Bureau	Ownership/Partnership/Principal	Personal Research	Institutional, Organizational, or Other Financial Benefit	Expert Witness
Geoffrey D. Barnes	Content Reviewer—ACC Expert	University of Michigan—Assistant Professor of Internal Medicine; Co-director, Michigan Anticoagulation Quality Improvement Initiative	▪Acelis Connected Health ▪AMAG Pharmaceuticals, Inc ▪Bristol Myers Squibb/Pfizer∗ ▪Janssen Pharmaceuticals, Inc	None	None	▪Blue Cross Blue Shield of Michigan∗	None	None
Diana Berrent	Content Reviewer—Patient Advocate	Survivor Corps—Founder	None	None	None	None	None	None
Devyani Chowdhury	Official Reviewer—ACC Adult Congenital & Pediatric Cardiology Council	Cardiology Care for Children and Ai Dupont Children's Hospital—Director of Cardiology Care for Children; Medical Director of ACHD at Nemour's	▪Tenaya Pharmaceuticals	None	None	▪Bill and Melinda Gates Foundation† ▪Hitachi Solutions†	None	None
Leslie T. Cooper	Content Reviewer—ACC Expert	Mayo Clinic—Professor of Medicine	▪Bristol Myers Squibb∗ ▪Cantargia, Inc. ▪Cardiol, Inc.∗	None	None	▪Moderna, Inc (DSMB)	▪Mayo Clinic, Florida Executive Oversight Team† ▪The Myocarditis Foundation†	None
Peter N Dean	Content Reviewer—ACC Expert	University of Virginia— Associate Professor	None	None	None	None	None	None
James L. Januzzi Jr.	Content Reviewer—ACC Expert	Harvard Medical School—Hutter Family Professor of Medicine; Director, Dennis and Marilyn Barry Fellowship in Cardiology Research; Senior Cardiometabolic Faculty, Baim Institute for Clinical Research	▪Abbott Laboratories ▪Imbria∗ ▪Novartis∗ ▪Roche Diagnostics∗	None	None	▪Abbott Laboratories∗ ▪AbbVie, Inc.∗ (DSMB) ▪Amgen∗ (DSMB) ▪Bayer Healthcare Pharmaceuticals∗ (DSMB) ▪Beyer∗ (DSMB) ▪CVRx∗ (DSMB) ▪Janssen Pharmaceuticals, Inc∗ ▪Takeda Pharmaceuticals North America, Inc∗ (DSMB)	None	None
Thomas M. Maddox	Content Reviewer—ACC Expert	BJC HealthCare and Washington University School of Medicine—Executive Director, Healthcare Innovation Lab; Professor of Medicine	None	None	None	▪NIH NCATS (1U24TR002306-01: A National Center for Digital Health Informatics Innovation)∗	▪BJC HealthCare/Washington University School of Medicine∗	None
Matthew Oster	Content Reviewer—ACC Expert	Children's Healthcare of Atlanta—Pediatric Cardiologist	None	None	None	None	None	None
Satish R. Raj	Content Reviewer—ACC Expert	University of Calgary & Alberta Health Services— Professor of Cardiac Sciences	▪Medscape ▪Spire Learning∗	None	None	▪Arena Pharmaceuticals (DSMB) ▪Canadian Institutes of Health Research (CIHR)∗ ▪Cardiac Arrhythmia Network of Canada (CANet)∗ ▪Confirm Rx SMART Registry, Abbott Labs‡ ▪Phase 3 Clinical Effect of TD-9855 for Treating snOH in Subjects With Primary Autonomic Failure, Theravance, Inc‡	▪American Autonomic Society† ▪Canadian Cardiovascular Society Academy† ▪Dysautonomia International†	▪2021, Defendant, Postural Tachycardia Syndrome
Ashwin Kumar Ravichandran	Official Reviewer—ACC Heart Failure & Transplant Council	St. Vincent Heart Center—Cardiologist	▪Abbott Laboratories∗ ▪Medtronic	▪Actelion∗ ▪Bayer Pharmaceuticals∗ ▪United Therapeutics∗	None	▪INCREASE, United Therapeutics‡ ▪MOMENTUM 3, Abbott Laboratories‡ ▪SOUTHPAW, United Therapeutics‡ ▪VICTORIA, Merck & Co., Inc.‡	None	None
Ashley Schenk	Official Reviewer—American Society of Health System Pharmacists	UK College of Pharmacy; University of Kentucky HealthCare—Acute Care Pharmacy Services; Cardiology Assistant Adjunct Professor	None	None	None	None	None	None
Ravi V. Shah	Content Reviewer—ACC Expert	Massachusetts General Hospital—Cardiologist	▪Best doctors∗ ▪Myokardia	None	None	None	None	None
Cynthia C. Taub	Official Reviewer—American Society of Echocardiography	Dartmouth Hitchcock Medical Center—Chief, Section of Cardiovascular Medicine	None	None	None	None	None	None
David E. Winchester	Official Reviewer—Solution Set Oversight Committee	University of Florida—Associate Professor of Medicine	None	None	None	None	▪Alachua County Medical Society Board of Directors†	None

This table represents all relationships of reviewers with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity or ownership of ≥$5,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to https://www.acc.org/Guidelines/About-Guidelines-and-Clinical-Documents/Relationships-with-Industry-Policy for definitions of disclosure categories or additional information about the ACC/AHA Disclosure Policy for Writing Committees.

ACC = American College of Cardiology; AHA = American Heart Association

^∗Significant relationship.

^†No financial benefit.

^‡Relationship with this company is limited to enrolling patients in clinical trials. This disclosure was entered under the Clinical Trial Enroller category in the ACC’s disclosure system. To appear in this category, the author acknowledges that there is no direct or institutional relationship with the trial sponsor as defined in the ACC/AHA Disclosure Policy for Writing Committees.